BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28191977)

  • 1. Sulfonation of Tyrosine as a Method To Improve Biodistribution of Peptide-Based Radiotracers: Novel
    Haskali MB; Denoyer D; Noonan W; Culinane C; Rangger C; Pouliot N; Haubner R; Roselt PD; Hicks RJ; Hutton CA
    Mol Pharm; 2017 Apr; 14(4):1169-1180. PubMed ID: 28191977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosynthesis and biodistribution of a prosthetic group (¹⁸F-FENMA) conjugated to cyclic RGD peptides.
    Olberg DE; Cuthbertson A; Solbakken M; Arukwe JM; Qu H; Kristian A; Bruheim S; Hjelstuen OK
    Bioconjug Chem; 2010 Dec; 21(12):2297-304. PubMed ID: 21070000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Contrast CXCR4-Targeted
    Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
    Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
    Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
    Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process.
    Pohle K; Notni J; Bussemer J; Kessler H; Schwaiger M; Beer AJ
    Nucl Med Biol; 2012 Aug; 39(6):777-84. PubMed ID: 22444238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
    Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
    Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.
    Maschauer S; Haubner R; Kuwert T; Prante O
    Mol Pharm; 2014 Feb; 11(2):505-15. PubMed ID: 24325589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step radiosynthesis of 4-nitrophenyl 2-[(18) F]fluoropropionate ([(18) F]NFP); improved preparation of radiolabeled peptides for PET imaging.
    Haskali MB; Roselt PD; Karas JA; Noonan W; Wichmann CW; Katsifis A; Hicks RJ; Hutton CA
    J Labelled Comp Radiopharm; 2013 Dec; 56(14):726-30. PubMed ID: 24339012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
    Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
    Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
    Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
    Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
    Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kit-like 18F-labeling of RGD-19F-arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging.
    Liu Z; Li Y; Lozada J; Wong MQ; Greene J; Lin KS; Yapp D; Perrin DM
    Nucl Med Biol; 2013 Aug; 40(6):841-9. PubMed ID: 23810487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Method for Radiolabeling and Dimerizing Thiolated Peptides Using (18)F-Hexafluorobenzene.
    Jacobson O; Yan X; Ma Y; Niu G; Kiesewetter DO; Chen X
    Bioconjug Chem; 2015 Oct; 26(10):2016-20. PubMed ID: 26086295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
    Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
    Lee YS; Jeong JM; Kim HW; Chang YS; Kim YJ; Hong MK; Rai GB; Chi DY; Kang WJ; Kang JH; Lee DS; Chung JK; Lee MC; Suh YG
    Nucl Med Biol; 2006 Jul; 33(5):677-83. PubMed ID: 16843843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
    Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
    J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
    Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
    Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.